| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
“Are changes in breast density during the menstrual cycle relevant? To what?”
|
Browne, Jean L.
|
|
|
183 |
2 |
p. 451-458
|
artikel
|
| 2 |
Assessing preferences for receiving supportive care resources among patients seen at a Breast Care Center
|
Wong, Emily C.
|
|
|
183 |
2 |
p. 381-389
|
artikel
|
| 3 |
CDH2/N-cadherin and early diagnosis of invasion in patients with ductal carcinoma in situ
|
Guvakova, Marina A.
|
|
|
183 |
2 |
p. 333-346
|
artikel
|
| 4 |
Clinical decision trees support systematic evaluation of multidisciplinary team recommendations
|
Hendriks, Mathijs P.
|
|
|
183 |
2 |
p. 355-363
|
artikel
|
| 5 |
Correction to: Frequency of heterozygous germline pathogenic variants in genes for Fanconi anemia in patients with non-BRCA1/BRCA2 breast cancer: a meta-analysis
|
Alter, Blanche P.
|
|
|
183 |
2 |
p. 491
|
artikel
|
| 6 |
Correction to: Palbociclib use with grade 3 neutropenia in hormone receptor-positive metastatic breast cancer
|
Ham, Ahrong
|
|
|
183 |
2 |
p. 493
|
artikel
|
| 7 |
Cost-effectiveness analyses demonstrate that observation is superior to sentinel lymph node biopsy for postmenopausal women with HR + breast cancer and negative axillary ultrasound
|
McEvoy, Aubriana M.
|
|
|
183 |
2 |
p. 251-262
|
artikel
|
| 8 |
Differential prognostic value of positive HER2 status determined by immunohistochemistry or fluorescence in situ hybridization in breast cancer
|
Stocker, Albina
|
|
|
183 |
2 |
p. 311-319
|
artikel
|
| 9 |
Dynamic contrast-enhanced magnetic resonance imaging for risk-stratified screening in women with BRCA mutations or high familial risk for breast cancer: are we there yet?
|
Whitaker, Kristen D.
|
|
|
183 |
2 |
p. 243-250
|
artikel
|
| 10 |
Endocrine treatment and incidence of relapse in women with oestrogen receptor-positive breast cancer in Europe: a population-based study
|
Sant, Milena
|
|
|
183 |
2 |
p. 439-450
|
artikel
|
| 11 |
Evaluation of a beneficial effect of adjuvant chemotherapy in patients with stage I triple-negative breast cancer: a population-based study using the SEER 18 database
|
Du, Zhong-Li
|
|
|
183 |
2 |
p. 429-438
|
artikel
|
| 12 |
External validation and modification of nomogram for predicting positive resection margins before breast conserving surgery
|
Jung, Ji-Jung
|
|
|
183 |
2 |
p. 373-380
|
artikel
|
| 13 |
Genetic and clinical predictors of arthralgia during letrozole or anastrozole therapy in breast cancer patients
|
Borrie, Adrienne E.
|
|
|
183 |
2 |
p. 365-372
|
artikel
|
| 14 |
Genetic mutation profile of Chinese HER2-positive breast cancers and genetic predictors of responses to Neoadjuvant anti-HER2 therapy
|
Li, Kai
|
|
|
183 |
2 |
p. 321-332
|
artikel
|
| 15 |
Impact of early dose intensity reduction of Palbociclib on clinical outcomes in patients with hormone-receptor-positive metastatic breast cancer
|
Moftakhar, Bahar
|
|
|
183 |
2 |
p. 411-418
|
artikel
|
| 16 |
Obesity and related conditions and risk of inflammatory breast cancer: a nested case–control study
|
Schairer, Catherine
|
|
|
183 |
2 |
p. 467-478
|
artikel
|
| 17 |
Overall survival results from the randomized phase 2 study of palbociclib in combination with letrozole versus letrozole alone for first-line treatment of ER+/HER2− advanced breast cancer (PALOMA-1, TRIO-18)
|
Finn, Richard S.
|
|
|
183 |
2 |
p. 419-428
|
artikel
|
| 18 |
Patient preferences for locoregional therapy in early-stage breast cancer
|
Minami, Christina A.
|
|
|
183 |
2 |
p. 291-309
|
artikel
|
| 19 |
Patient-reported acute fatigue in elderly breast cancer patients treated with and without regional nodal radiation
|
Misra, Shagun
|
|
|
183 |
2 |
p. 391-401
|
artikel
|
| 20 |
Racial differences in the relationship between surgical choice and subsequent patient-reported satisfaction outcomes among women with early-stage hormone-positive breast cancer
|
Arabandi, Prudvi
|
|
|
183 |
2 |
p. 459-466
|
artikel
|
| 21 |
Spatial location of local recurrences after mastectomy: a systematic review
|
Kaidar-Person, Orit
|
|
|
183 |
2 |
p. 263-273
|
artikel
|
| 22 |
The shape of breast cancer
|
Byrd, Brook K.
|
|
|
183 |
2 |
p. 403-410
|
artikel
|
| 23 |
TRAF4, a new substrate of SIAH1, participates in chemotherapy resistance of breast cancer cell by counteracting SIAH1-mediated downregulation of β-catenin
|
Ren, Huayan
|
|
|
183 |
2 |
p. 275-289
|
artikel
|
| 24 |
Tumor-infiltrating lymphocytes (TILs) in ER+/HER2− breast cancer
|
Criscitiello, C.
|
|
|
183 |
2 |
p. 347-354
|
artikel
|
| 25 |
Variation in pathological complete response in HER2-positive breast cancers with intrinsic subtypes assessed by PAM50 testing: secondary analysis from NSABP B-41 trial
|
Goel, Arun Kumar
|
|
|
183 |
2 |
p. 489-490
|
artikel
|
| 26 |
Venous thromboembolism risk in patients with hormone receptor-positive HER2-negative metastatic breast cancer treated with combined CDK 4/6 inhibitors plus endocrine therapy versus endocrine therapy alone: a systematic review and meta-analysis of randomized controlled trials
|
Thein, Kyaw Zin
|
|
|
183 |
2 |
p. 479-487
|
artikel
|
Tijdschrift beschrijving